RNAi Crashes The PCSK9 Party

RNAi Crashes The PCSK9 Party

Newest Hopeful In Cholesterol Lowering Landscape Just weeks after the biotech world celebrated the approvals of two new cholesterol-lowering PCSK9 inhibitors, Regeneron/Sanofi’s Praulent and Amgen’s Repatha, a potential future rival arrived in style....
12 Biotech Concepts Everyone Should Know

12 Biotech Concepts Everyone Should Know

Our mission here at WEEKLY is to keep your industry knowledge up to date. We will be off Thursday, roasting our turkeys and reminding ourselves that it is not the amino acid tryptophan that makes us drowsy after a Thanksgiving feast—it is the massive carbohydrate...
Cultivating Biologics From Plants?

Cultivating Biologics From Plants?

A FRESH LOOK AT TOBACCO AND BIOLOGICS Tobacco plants pioneering the production of monoclonal antibodies for an experimental Ebola treatment turned out to be quite the head scratcher for last Thursday’s WEEKLY readers. With tobacco’s reputation polluting our...

RNAi Advantage Goes To Dicerna

THE SCIENCE BEHIND THE IPO CRAZE: OUR FOCUS FOR THE NEXT FEW WEEKS I want to thank you for subscribing to Biotech Primer WEEKLY. Now, imagine yourself on the set of Jeopardy! facing this clue: “We saw 45 in 2013, and there’s been 17 so far this...